Get the Stockscreener App
0.93
8.47%
0.0726
After Hours:
.90
-0.03
-3.23%
Cosmos Health Inc stock is traded at $0.93, with a volume of 1.79M.
It is up +8.47% in the last 24 hours and up +59.55% over the past month.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.
See More
Previous Close:
$0.8574
Open:
$0.87
24h Volume:
1.79M
Relative Volume:
6.01
Market Cap:
$21.63M
Revenue:
$49.59M
Net Income/Loss:
$-15.61M
P/E Ratio:
-0.2326
EPS:
-3.9981
Net Cash Flow:
$-32.55M
1W Performance:
+35.23%
1M Performance:
+59.55%
6M Performance:
-25.00%
1Y Performance:
-13.89%
1-Day Range:
$0.835
$1.05
1-Week Range:
$0.6998
$1.05
52-Week Range:
$0.4677
$1.58
Cosmos Health Inc Stock (COSM) Company Profile
Name
Cosmos Health Inc
Sector
Industry
Phone
312-536-3102
Address
5 AGIOU GEORGIOU, PILEA, THESSALONIKI
Compare COSM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
COSM
Cosmos Health Inc
|
0.93 | 21.63M | 49.59M | -15.61M | -32.55M | -3.9981 |
|
MCK
Mckesson Corporation
|
586.08 | 76.02B | 330.19B | 2.54B | 4.31B | 19.31 |
|
COR
Cencora Inc
|
245.07 | 47.37B | 293.96B | 1.51B | 3.00B | 7.51 |
|
CAH
Cardinal Health Inc
|
127.83 | 31.14B | 224.34B | 1.26B | 1.08B | 5.14 |
|
HSIC
Henry Schein Inc
|
74.19 | 8.72B | 12.50B | 314.00M | 421.00M | 2.44 |
|
PDCO
Patterson Companies Inc
|
30.95 | 2.72B | 6.55B | 155.22M | -823.13M | 1.71 |
Cosmos Health Inc Stock (COSM) Latest News
Cosmos Health CEO Greg Siokas Acquires a Total of 647,809 Shares Valued at $425,000 Over the Past 32 Days - Yahoo Finance
Cosmos Health CEO acquires $25,000 in stock through debt exchange - MSN
Head-To-Head Comparison: Aceto (OTCMKTS:ACETQ) versus Cosmos Health (NASDAQ:COSM) - Defense World
Aceto (OTCMKTS:ACETQ) versus Cosmos Health (NASDAQ:COSM) Financial Comparison - Defense World
Cosmos health CEO Siokas acquires shares in $40,000 debt exchange - MSN
Market Might Still Lack Some Conviction On Cosmos Health Inc. (NASDAQ:COSM) Even After 31% Share Price Boost - Simply Wall St
Cosmos Health CEO Grigorios Siokas acquires $50,000 in stock - MSN
Cosmos health CEO Siokas acquires shares in $40,000 debt exchange By Investing.com - Investing.com UK
Cosmos Health CEO Grigorios Siokas acquires $50,000 in stock By Investing.com - Investing.com UK
Cosmos Health CEO acquires shares worth $60,000 By Investing.com - Investing.com Australia
Cosmos Health CEO acquires shares worth $60,000 - Investing.com India
Cosmos Health CEO acquires $100,000 in stock via debt exchange By Investing.com - Investing.com Australia
Cosmos Health CEO acquires $100,000 in stock via debt exchange - Investing.com India
Cosmos Health secures exclusive distribution agreement with Virax Biolabs - Yahoo Finance
Cosmos Health Secures Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Greece and Cyprus, with Additional Rights in Select European and GCC Countries - AccessWire
Cosmos Health Secures Multi-Country Distribution Rights for Advanced Avian Flu Test Kits - StockTitan
Cosmos Health appoints new head of oncology R&D By Investing.com - Investing.com Canada
Cosmos Health CEO Grigorios Siokas acquires $150,000 in stock - Investing.com India
Cosmos health CFO Georgios Terzis acquires shares worth $49,999 By Investing.com - Investing.com Canada
Cosmos Health CEO Grigorios Siokas acquires $150,000 in stock By Investing.com - Investing.com Canada
Cosmos health CFO Georgios Terzis acquires shares worth $49,999 - Investing.com India
Cosmos Health appoints new head of oncology R&D - Investing.com
Cosmos Health Strengthens R&D Leadership and Innovation with the Appointment of Professor Dimitrios Trafalis, MD, as Head of Oncology - AccessWire
Cosmos Health (COSM) Strengthens R&D Division, Appoints Leading Oncology Expert Prof. Trafalis as Head of Oncology - StockTitan
Reviewing Cosmos Health (NASDAQ:COSM) and Aceto (OTCMKTS:ACETQ) - Defense World
Cosmos Health CEO Greg Siokas and CFO George Terzis Collectively Increase Stake by 343,000 Shares Valued at $200,000 - AccessWire
Cosmos Health CEO, CFO Show Confidence with $200K Insider Stock Purchase Amid Growth Plans - StockTitan
Cosmos Health (NASDAQ:COSM) Stock Price Down 5.7% – Here’s Why - Defense World
Taglich Brothers Releases Updated Coverage on Cosmos Health: Projects Positive EPS for 2025 and Sets $3 Price Target, Nearly 300% Above Current Share Price - AccessWire
Cosmos Health Projects 25% Revenue Growth to $68.4M by 2025, Taglich Maintains Buy Rating | COSM Stock News - StockTitan
Cosmos Health Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Cosmos Health shareholders approve key proposals - Investing.com
Cosmos Health Picks Bitcoin for Its Treasury - Altcoin Buzz
Cosmos Health adds Bitcoin and Ethereum to treasury reserves - MSN
Cosmos Health to accumulate BTC and Ethereum and accept crypto payments - TU News
Planning Ahead: Cosmos Health Looks to Add Bitcoin and Ethereum to Its Treasury - Bitcoin.com News
More companies name BTC a treasury reserve asset - Blockworks
Another Publicly Traded Company Adds Bitcoin to Its Balance Sheet - Decrypt
Cosmos Health integrates bitcoin, ethereum as treasury reserve assets - TipRanks
Cosmos Health Inc Stock (COSM) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.32%
3.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):